Another week, another major development at Nano Dimension, which throws everything said previously upside down.
biotech
The Biotech Investment Backstop — And What It Means for 3D Printing
Charles R. Goulding and Preeti Sulibhavi demonstrate how biotech is getting a boost from stronger pharma buyers, smarter use of 3D printing, and new OBBBA tax incentives that make early-stage R&D far easier to fund.
From Wet Labs to 3D Printing: NYU Langone Powers NYC’s Medical Renaissance
Charles R. Goulding and Kate Esposito delve into how NYU Langone is reshaping New York City’s medical innovation landscape through cutting-edge research centers, 3D printing advancements, and programs empowering the next generation of healthcare entrepreneurs.